Login to Your Account

Killing bacteria isn't enough

New antibiotics hit their target

By Brian Orelli
Staff Writer

Monday, September 11, 2017

Both Summit Therapeutics plc and Insmed Inc. have taken wiping out bacteria to the next level, releasing separate clinical trial data last week that show their drugs target specific bacteria and reach hard-to-treat places in the lung that bacteria hide, respectively.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription